Wies van Roosmalen

439 total citations
7 papers, 351 citations indexed

About

Wies van Roosmalen is a scholar working on Cell Biology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Wies van Roosmalen has authored 7 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cell Biology, 3 papers in Molecular Biology and 3 papers in Immunology and Allergy. Recurrent topics in Wies van Roosmalen's work include Cellular Mechanics and Interactions (5 papers), Cell Adhesion Molecules Research (3 papers) and Cell Image Analysis Techniques (2 papers). Wies van Roosmalen is often cited by papers focused on Cellular Mechanics and Interactions (5 papers), Cell Adhesion Molecules Research (3 papers) and Cell Image Analysis Techniques (2 papers). Wies van Roosmalen collaborates with scholars based in Netherlands, United States and Israel. Wies van Roosmalen's co-authors include Xiaohong Chen, Xiaoyan Song, Jonathan Backer, Vera DesMarais, Jacco van Rheenen, Shu-Chin Yip, Robert J. Eddy, John S. Condeelis, Michael Cammer and Bob van de Water and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Cell Biology and Clinical & Experimental Metastasis.

In The Last Decade

Wies van Roosmalen

7 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wies van Roosmalen Netherlands 5 196 164 68 55 43 7 351
Christiane Oddou France 11 227 1.2× 232 1.4× 127 1.9× 97 1.8× 27 0.6× 17 447
Pablo Hernández-Varas Sweden 8 161 0.8× 145 0.9× 99 1.5× 55 1.0× 44 1.0× 12 333
Daniela Leyton-Puig Netherlands 9 228 1.2× 194 1.2× 67 1.0× 24 0.4× 75 1.7× 9 422
Rob van der Kammen Netherlands 9 306 1.6× 272 1.7× 68 1.0× 45 0.8× 20 0.5× 10 520
Sandra de Keijzer Netherlands 10 186 0.9× 136 0.8× 77 1.1× 49 0.9× 38 0.9× 13 411
Nicolas Molinié France 7 158 0.8× 166 1.0× 33 0.5× 55 1.0× 23 0.5× 7 306
Martin J. Baker United States 13 243 1.2× 109 0.7× 37 0.5× 53 1.0× 16 0.4× 20 341
Beth E. Drees United States 7 254 1.3× 232 1.4× 90 1.3× 35 0.6× 15 0.3× 9 418
Kuan Yan Netherlands 12 203 1.0× 75 0.5× 41 0.6× 89 1.6× 39 0.9× 23 373
Marco Biondini France 9 156 0.8× 134 0.8× 32 0.5× 86 1.6× 15 0.3× 11 323

Countries citing papers authored by Wies van Roosmalen

Since Specialization
Citations

This map shows the geographic impact of Wies van Roosmalen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wies van Roosmalen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wies van Roosmalen more than expected).

Fields of papers citing papers by Wies van Roosmalen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wies van Roosmalen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wies van Roosmalen. The network helps show where Wies van Roosmalen may publish in the future.

Co-authorship network of co-authors of Wies van Roosmalen

This figure shows the co-authorship network connecting the top 25 collaborators of Wies van Roosmalen. A scholar is included among the top collaborators of Wies van Roosmalen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wies van Roosmalen. Wies van Roosmalen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Roosmalen, Wies van, et al.. (2019). Paxillin serine 178 phosphorylation in control of cell migration and metastasis formation through regulation of EGFR expression in breast cancer. Journal of Cancer Metastasis and Treatment. 2019. 3 indexed citations
2.
Roosmalen, Wies van, et al.. (2016). PhagoKinetic Track Assay: Imaging and Analysis of Single Cell Migration. BIO-PROTOCOL. 6(1). 3 indexed citations
3.
Roosmalen, Wies van, Sylvia E. Le Dévédec, Ofra Golani, et al.. (2015). Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant. Journal of Clinical Investigation. 125(4). 1648–1664. 98 indexed citations
4.
Roosmalen, Wies van, et al.. (2011). Functional Screening with a Live Cell Imaging-Based Random Cell Migration Assay. Methods in molecular biology. 769. 435–448. 11 indexed citations
5.
Dévédec, Sylvia E. Le, Wies van Roosmalen, Chantal Pont, et al.. (2011). Two-Photon Intravital Multicolour Imaging to Study Metastatic Behaviour of Cancer Cells In Vivo. Methods in molecular biology. 769. 331–349. 10 indexed citations
6.
Dévédec, Sylvia E. Le, Wies van Roosmalen, Naomi S. Sta Maria, et al.. (2009). An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2−/− γc−/− mouse. Clinical & Experimental Metastasis. 26(7). 673–684. 24 indexed citations
7.
Rheenen, Jacco van, Xiaoyan Song, Wies van Roosmalen, et al.. (2007). EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells. The Journal of Cell Biology. 179(6). 1247–1259. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026